Citations

Clear

479 citation(s) found for "Tobias, JS".

Reply by Authors
Kaplan, Steven A. , Köhler, Tobias , Kausik, Sankar J.

Mayo Clinic

Journal of Urology | September 28, 2020 | Volume: 204 | Issue: 6 | Pages: 1304-1304

10.1097/ju.0000000000001195.03 | PMID 32986495 Get It

Increased body mass index is associated with decreased imaging quality of point‐of‐care abdominal aortic ultrasonography
Jeeji, Archana K., Ekstein, Samuel F. , Ifelayo, Oluwatomilona I., Oyemade, Kafayat A. , Tawfic, Sarah, Hyde, Robert J. , Laughlin, Michael J., Lohse, Christine M. , Kummer, Tobias , Bellamkonda, Venkatesh R. , Ifelayo, Oluwatomilona , Tawfic, Sarah S, Bellamkonda, Venkatesh R , Mullan, Aidan F.

Mayo Clinic

Journal of Clinical Ultrasound | September 28, 2020 | Volume: 49 | Issue: 4 | Pages: 328-333

10.1002/jcu.22929 | PMID 32984964 Get It

AbstractBackgroundGiven that abdominal aorta is a retroperitoneal structure, increased body mass index (BMI) may have an adverse effect upon the quality of aortic ultrasonographic imaging.PurposeTo assess the hypothesis that increased BMI is associated with worsening point‐of‐care abdominal aortic ultrasonographic image quality.MethodsThis is a retrospective single‐center study of point‐of‐care abdominal aortic ultrasound examinations performed in an academic emergency department (ED) with fellowship‐trained emergency ultrasonography faculty performing quality assurance review.ResultsMean ± SD BMI was 27.4 ± 6.2, among the 221 included records. The overall quality rating decreased as BMI increased (correlation coefficient − 0.24; P < .001) and this persisted after adjustment for age and sex (P < .001). Although BMI was higher on average in the records that were of insufficient quality for clinical decisions when compared with those of sufficient quality (mean BMI 28.7 vs 27.0), this did not reach statistical significance in a univariable setting (P = .11) or after adjusting for age and sex (P = .14).ConclusionThis study data shows a decrease in point‐of‐care abdominal aorta ultrasound imaging quality as BMI increases, though this difference did not result in a statistically significant impairment in achieving the minimum quality for clinical decisions. This finding may help ameliorate some clinician concerns about ultrasonography for patients with high BMI.
First-line medication dosing in pediatric refractory status epilepticus
Vasquez, Alejandra , Gaínza‐Lein, Marina , Amengual‐Gual, Marta , Anderson, Anne E. , Arya, Ravindra , Brenton, J. Nicholas , Carpenter, Jessica L. , Chapman, Kevin , Clark, Justice , Farias‐Moeller, Raquel , Gaillard, William D. , Goldstein, Joshua , Goodkin, Howard P. , McDonough, Tiffani L. , Mikati, Mohamad A. , Morgan, Lindsey A. , Ostendorf, Adam P. , Payne, Eric T. , Peariso, Katrina , Piantino, Juan , Riviello, James J. , Sannagowdara, Kumar , Tasker, Robert C. , Tchapyjnikov, Dmitry , Topjian, Alexis , Wainwright, Mark S. , Wilfong, Angus A. , Williams, Korwyn, Kelley, Sarah A. , Stafstrom, Carl E. , Kossoff, Eric H. , Lewis, Dalila, Stanfield, Tony, Sculier, Claudine , Sansevere, Arnold J. , Sacco, Melissa, Duncan, Abby, McCoy, Jordan, DaSilva-Chiodo, Kathryn, Faist, Robert, Santel, D., LaFay, Victor , Clark, Peggy O., Borror, Sarah, Debs, Andrea, Clohessy, Caitlin, Weber, Amanda , Yuliati, Asri, Luat, Aimée F. , Singh, Azara, Helseth, Ashley , Fernandes, Cecilia, Tran, Linh , McLean, Melissa, Nayak, Anuranjita , Hecox, Kurt, Nallamothu, R. K., Rehborg, Rebecca, Goldstein, David B., Cox, Erin Heinzen, Malone, Colin D., Thornburg, Olivia , Basma, Natasha, Burrows, Brian T., Dyar, Beata, Mishler, Laura, Lee‐Eng, Jacqueline , Streb, Madison, Ganesan, Saptharishi Lalgudi , Huh, Linda , Martic, Nela, Abend, Nicholas S. , Amengual-Gual, Marta, Anderson, Anne, Arya, Ravindra , Brenton, J Nicholas , Farias-Moeller, Raquel, Glauser, Tracy, Goldstein, Joshua L, Guerriero, Rejean M , Kapur, Kush , Lai, Yi‐Chen , Novotny, Edward J , Payne, Eric T , Tasker, Robert C , Tchapyjnikov, Dmitry , Wainwright, Mark S , Wilfong, Angus, Loddenkemper, Tobias , Gaillard, William D , Mikati, Mohamad A , Morgan, Lindsey A , Glauser, Tracy A. , Novotny, Edward J. , Bansal, Seema, Habela, Christa Whelan , Aguilar, Cristina Barcia , Santel, Daniel, LaFay, Victor, Turner, David A. , Nallamothu, Rupa, Grinspan, Zachary M. , Appavu, Brian , Hahn, Cecil D.

Mayo Clinic

Neurology | September 11, 2020 | Volume: 95 | Issue: 19 | Pages: No page available

10.1212/wnl.0000000000010828 | PMID 32913024 Get It

Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction
Horiuchi, Yu , Wettersten, Nicholas , Patel, Mitul , Mueller, Christian, Neath, Sean‐Xavier , Christenson, Robert H. , Morgenthaler, Nils G., McCord, James , Nowak, Richard M. , Vilke, Gary M. , Daniels, Lori B. , Apple, Fred S. , Cannon, Chad , Nagurney, John Tobias , Schreiber, Donald , Diercks, Deborah B. , Headden, Gary , Limkakeng, Alexander T. , Wu, Alan H.B. , Ebmeyer, Stefan , Jaffe, Allan S. , Peacock, W. Frank, Maisel, Alan , Müller, Christian , Mueller, Christian , Daniels, Lori B , Hollander, Judd E. , deFilippi, Christopher R. , Hogan, Christopher J. , Anand, Inder S. , Jaffe, Allan S.

Mayo Clinic

Circulation | August 21, 2020 | Volume: 142 | Issue: 16 | Pages: 1532-1544

10.1161/circulationaha.120.046682 | PMID 32820656 Get It

Background: The observed incidence of type 2 myocardial infarction (T2MI) is expected to increase with the implementation of increasingly sensitive cTn assays. However, it remains to be determined how to diagnose, risk-stratify, and treat patients with T2MI. We aimed to discriminate and risk-stratify T2MI using biomarkers. Methods: Patients presenting to the emergency department with chest pain, enrolled in the CHOPIN study (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction), were retrospectively analyzed. Two cardiologists adjudicated type 1 MI (T1MI) and T2MI. The prognostic ability of several biomarkers alone or in combination to discriminate T2MI from T1MI was investigated using receiver operating characteristic curve analysis. The biomarkers analyzed were cTnI, copeptin, MR-proANP (midregional proatrial natriuretic peptide), CT-proET1 (C-terminal proendothelin-1), MR-proADM (midregional proadrenomedullin), and procalcitonin. The prognostic utility of these biomarkers for all-cause mortality and major adverse cardiovascular event (a composite of acute myocardial infarction, unstable angina pectoris, reinfarction, heart failure, and stroke) at 180-day follow-up was also investigated. Results: Among the 2071 patients, T1MI and T2MI were adjudicated in 94 and 176 patients, respectively. Patients with T1MI had higher levels of baseline cTnI, whereas those with T2MI had higher baseline levels of MR-proANP, CT-proET1, MR-proADM, and procalcitonin. The area under the receiver operating characteristic curve for the diagnosis of T2MI was higher for CT-proET1, MR-proADM, and MR-proANP (0.765, 0.750, and 0.733, respectively) than for cTnI (0.631). Combining all biomarkers resulted in a similar accuracy to a model using clinical variables and cTnI (0.854 versus 0.884, P =0.294). Addition of biomarkers to the clinical model yielded the highest area under the receiver operating characteristic curve (0.917). Other biomarkers, but not cTnI, were associated with mortality and major adverse cardiovascular event at 180 days among all patients, with no interaction between the diagnosis of T1MI or T2MI. Conclusions: Assessment of biomarkers reflecting pathophysiologic processes occurring with T2MI might help differentiate it from T1MI. All biomarkers measured, except cTnI, were significant predictors of prognosis, regardless of the type of myocardial infarction.
Retrospective observational study on hospital readmission for status epilepticus in the United States over 2016
Amengual‐Gual, Marta , Fernández, Iván Sánchez , Vasquez, Alejandra , Loddenkemper, Tobias , Sánchez Fernández, Iván , Loddenkemper, Tobias

Mayo Clinic

Epilepsia | July 19, 2020 | Volume: 61 | Issue: 7 | Pages: 1386-1396

10.1111/epi.16586 | PMID 32683696 Get It

AbstractObjectiveDescribe hospital readmission for status epilepticus (SE) in the United States, and study potential risk factors for readmission.MethodsThis is a retrospective observational study using the Healthcare Cost and Utilization Project's 2016 Nationwide Readmissions Database. We studied patients of all ages admitted to the hospital due to SE.ResultsWe included 32 327 patients admitted for SE in 2016. 8.4% of these patients were readmitted for SE at least one more time within 2016 (cross‐sectional analysis). The incidence rate was 18 readmissions for SE per 1000 patient‐months. Among the survivors of the index admission for SE who had at least 6 months of follow‐up within this database (16 043 patients), the cumulative probability of having a readmission for SE at 1, 3, and 6 months from the index admission was approximately 3.5%, 7.5%, and 11%, respectively (time‐to‐event analysis). Patients with refractory epilepsy were more likely to have a readmission for SE compared to patients without refractory epilepsy (hazard ratio [HR] 1.49, 95% confidence interval [CI] 1.23‐1.82, adjusted P =.0006), and pediatric patients were more likely to have a readmission for SE compared to adult patients (HR 1.53, 95% CI 1.26‐1.87, adjusted P = .0003) during 6‐month follow‐up.SignificanceHospital readmissions for SE in the United States are frequent. Independent factors associated with readmission in this database were refractory epilepsy and pediatric age.
Treatment of Alpha 1 Antitrypsin Deficiency Related Panniculitis with Alpha 1 Antitrypsin Infusion
Rusk, A.W., Pride, Renee, Peikert, Tobias, el‐Azhary, Rokea A.

Mayo Clinic

B37. CASE REPORTS IN COUGH AND AIRWAYS DISEASE | July 8, 2020 | Volume: No volume available | Issue: No issue available | Pages: A3163-A3163

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3163 Get It

Multiple Pulmonary Masses Provide a Diagnostic Conundrum
Peikert, Tobias, Kelly, B.

Mayo Clinic

C68. THORACIC ONCOLOGY CASE REPORTS II | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A5765-A5765

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5765 Get It

Active and Latent Tuberculosis Infection in Patients Taking Immune Checkpoint Inhibitors
Stroh, Gregory R., Peikert, Tobias, Escalante, Patricio

Mayo Clinic

C53. GLOBAL EXPERIENCES IN TB AND NTM CARE | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A5434-A5434

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5434 Get It

Longitudinal Radiological Characterization of Clinically Indolent and Aggressive Lung Adenocarcinomas Using Computer Aided Nodule Analysis and Risk Yield (CANARY)
Khawaja, Ali , Rajagopalan, S., Karwoski, Ronald A., Maldonado, Fabien , Peikert, Tobias, Rajagopalan, S., Bartholmai, Brian J.

Mayo Clinic

B110. IMAGING AND MOLECULAR BIOMARKERS FOR LUNG CANCER | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A4466-A4466

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4466 Get It

Can Longitudinal Analysis of Computer Tomography-Based Score Indicative of Lung Cancer Aggression (SILA) Help in the Early Characterization of Lung Adenocarcinoma?
Lakhani, Dhairya A. , Roller, Lance, Chen, H. , Karwoski, R., Rajagopalan, S., Peikert, Tobias, Massion, Pierre P. , Maldonado, Fabien , Lakhani, Dhairya , Balar, Aneri , Antic, S., Kammer, Michael N. , Rajagopalan, S.

Mayo Clinic

D99. ADVANCING RISK ASSESSEMENT FOR PULMONARY NODULES | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A7692-A7692

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7692 Get It